These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 35177282

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Our initial learning curve in the enzymatic debridement of severely burned hands-Management and pit falls of initial treatments and our development of a post debridement wound treatment algorithm.
    Schulz A, Perbix W, Shoham Y, Daali S, Charalampaki C, Fuchs PC, Schiefer J.
    Burns; 2017 Mar; 43(2):326-336. PubMed ID: 28341257
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of Bromelain-Based Enzymatic Debridement Combined with Laser Doppler Imaging and Healing of Burn Wounds.
    Korzeniowski T, Strużyna J, Torres K.
    Med Sci Monit; 2022 Aug 03; 28():e936713. PubMed ID: 35918878
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Enzymatic debridement of deeply burned faces: Healing and early scarring based on tissue preservation compared to traditional surgical debridement.
    Schulz A, Fuchs PC, Rothermundt I, Hoffmann A, Rosenberg L, Shoham Y, Oberländer H, Schiefer J.
    Burns; 2017 Sep 03; 43(6):1233-1243. PubMed ID: 28363663
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Eschar removal by bromelain based enzymatic debridement (Nexobrid®) in burns: European consensus guidelines update.
    Hirche C, Kreken Almeland S, Dheansa B, Fuchs P, Governa M, Hoeksema H, Korzeniowski T, Lumenta DB, Marinescu S, Martinez-Mendez JR, Plock JA, Sander F, Ziegler B, Kneser U.
    Burns; 2020 Jun 03; 46(4):782-796. PubMed ID: 32241591
    [Abstract] [Full Text] [Related]

  • 9. Assessing the Effect of Enzymatic Debridement on the Scar Quality in Partial-Thickness Burns to Deep Dermal Burns of the Hand: A Long-Term Evaluation.
    Heitzmann W, Schulz A, Fuchs PC, Schiefer JL.
    Medicina (Kaunas); 2024 Mar 14; 60(3):. PubMed ID: 38541207
    [Abstract] [Full Text] [Related]

  • 10. The process to obtain reimbursement for enzymatic debridement in clinically deep burns.
    Claes K, Hoeksema H, Lafaire C, De Cuyper L, De Groote K, Vyncke T, De Decker I, Verbelen J, De Coninck P, Depypere B, Monstrey S.
    Acta Chir Belg; 2023 Jun 14; 123(3):290-300. PubMed ID: 34766873
    [Abstract] [Full Text] [Related]

  • 11. A Questionnaire-Based Study to Obtain a Consensus from 5 Polish Burns Centers on Eschar Removal by Bromelain-Based Enzymatic Debridement (Nexobrid®) in Burns Following the 2020 Updated European Consensus Guidelines.
    Korzeniowski T, Strużyna J, Chrapusta AM, Krajewski A, Kucharzewski M, Piorun K, Nowakowski J, Surowiecka A, Kozicka M, Torres K.
    Med Sci Monit; 2022 Jan 22; 28():e935632. PubMed ID: 35064095
    [Abstract] [Full Text] [Related]

  • 12. Enzymatic debridement: past, present, and future.
    De Decker I, De Graeve L, Hoeksema H, Monstrey S, Verbelen J, De Coninck P, Vanlerberghe E, Claes KEY.
    Acta Chir Belg; 2022 Aug 22; 122(4):279-295. PubMed ID: 35440290
    [Abstract] [Full Text] [Related]

  • 13. A Retrospective Review of an Off-label Bromelain-based Selective Enzymatic Debridement (Nexobrid®) in the Treatment of Deep, Partial, and Full Thickness Burns and Hard to Heal Wounds.
    Harats M, Haik J, Cleary M, Vashurin I, Aviv U, Kornhaber R.
    Isr Med Assoc J; 2020 Feb 22; 22(2):83-88. PubMed ID: 32043324
    [Abstract] [Full Text] [Related]

  • 14. An Overview of the Use of Bromelain-Based Enzymatic Debridement (Nexobrid®) in Deep Partial and Full Thickness Burns: Appraising the Evidence.
    Loo YL, Goh BKL, Jeffery S.
    J Burn Care Res; 2018 Oct 23; 39(6):932-938. PubMed ID: 29579268
    [Abstract] [Full Text] [Related]

  • 15. Enzymatic Debridement With Nexobrid®Reduces Surgery in Laser Doppler Imaging-Confirmed Deep Burns.
    Claes KEY, De Decker I, Vyncke T, Verbelen J, Dhooghe N, Monstrey S, Hoeksema H.
    Ann Burns Fire Disasters; 2023 Dec 23; 36(4):347-354. PubMed ID: 38680243
    [Abstract] [Full Text] [Related]

  • 16. To bleed or not to bleed? Case series and discussion of haemorrhage risk with enzymatic debridement in burn injuries.
    Hasham S, Riyat H, Fletcher A, O'Boyle CP, Alexander S.
    Scars Burn Heal; 2023 Dec 23; 9():20595131231168333. PubMed ID: 37124159
    [Abstract] [Full Text] [Related]

  • 17. Clinical Value of Debriding Enzymes as an Adjunct to Standard Early Surgical Excision in Human Burns: A Systematic Review.
    Salehi SH, Momeni M, Vahdani M, Moradi M.
    J Burn Care Res; 2020 Nov 30; 41(6):1224-1230. PubMed ID: 32424404
    [Abstract] [Full Text] [Related]

  • 18. A novel rapid and selective enzymatic debridement agent for burn wound management: a multi-center RCT.
    Rosenberg L, Krieger Y, Bogdanov-Berezovski A, Silberstein E, Shoham Y, Singer AJ.
    Burns; 2014 May 30; 40(3):466-74. PubMed ID: 24074719
    [Abstract] [Full Text] [Related]

  • 19. Rapid and selective enzymatic debridement of porcine comb burns with bromelain-derived Debrase: acute-phase preservation of noninjured tissue and zone of stasis.
    Singer AJ, McClain SA, Taira BR, Rooney J, Steinhauff N, Rosenberg L.
    J Burn Care Res; 2010 May 30; 31(2):304-9. PubMed ID: 20182376
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.